APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs For Travelers' Diarrhea (TD)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drugs For Travelers' Diarrhea (TD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025180 pages

Choose your research edition.

Industry ResearchDrugs For Travelers' Diarrhea (TD) Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs For Travelers' Diarrhea (TD) Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Drugs For Travelers' Diarrhea (TD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs For Travelers' Diarrhea (TD) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs For Travelers' Diarrhea (TD) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Drugs For Travelers' Diarrhea (TD) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drugs For Travelers' Diarrhea (TD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs For Travelers' Diarrhea (TD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs For Travelers' Diarrhea (TD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drugs For Travelers' Diarrhea (TD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs For Travelers' Diarrhea (TD) include Sun Pharmaceutical Industries Ltd., Johnson & Johnson, Bayer AG, Valneva SE, Perrigo Company Plc, Norgine, Immuron, COSMO PHARMACEUTICALS and Bausch Health Companies Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drugs For Travelers' Diarrhea (TD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs For Travelers' Diarrhea (TD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs For Travelers' Diarrhea (TD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drugs For Travelers' Diarrhea (TD) market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs For Travelers' Diarrhea (TD) Segment by Company

Sun Pharmaceutical Industries Ltd.

Johnson & Johnson

Bayer AG

Valneva SE

Perrigo Company Plc

Norgine

Immuron

COSMO PHARMACEUTICALS

Bausch Health Companies Inc.

Drugs For Travelers' Diarrhea (TD) Segment by Type

Antidiarrheal Agents

Oral Rehydration Therapy (ORS)

Antibiotics

Others

Drugs For Travelers' Diarrhea (TD) Segment by Application

Adults

Children

Drugs For Travelers' Diarrhea (TD) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs For Travelers' Diarrhea (TD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs For Travelers' Diarrhea (TD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs For Travelers' Diarrhea (TD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drugs For Travelers' Diarrhea (TD) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drugs For Travelers' Diarrhea (TD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drugs For Travelers' Diarrhea (TD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drugs For Travelers' Diarrhea (TD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drugs For Travelers' Diarrhea (TD) Industry Trends Table 2. Drugs For Travelers' Diarrhea (TD) Industry Drivers Table 3. Drugs For Travelers' Diarrhea (TD) Industry Opportunities and Challenges Table 4. Drugs For Travelers' Diarrhea (TD) Industry Restraints Table 5. Global Drugs For Travelers' Diarrhea (TD) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drugs For Travelers' Diarrhea (TD) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Manufacturers Table 9. Global Drugs For Travelers' Diarrhea (TD) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Drugs For Travelers' Diarrhea (TD) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drugs For Travelers' Diarrhea (TD) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drugs For Travelers' Diarrhea (TD) Manufacturers, Product Type & Application Table 13. Global Drugs For Travelers' Diarrhea (TD) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drugs For Travelers' Diarrhea (TD) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Antidiarrheal Agents Table 17. Major Manufacturers of Oral Rehydration Therapy (ORS) Table 18. Major Manufacturers of Antibiotics Table 19. Major Manufacturers of Others Table 20. Global Drugs For Travelers' Diarrhea (TD) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Drugs For Travelers' Diarrhea (TD) Sales by Type (2021-2026) & (K Units) Table 22. Global Drugs For Travelers' Diarrhea (TD) Sales by Type (2027-2032) & (K Units) Table 23. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Type (2021-2026) Table 24. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Type (2027-2032) Table 25. Global Drugs For Travelers' Diarrhea (TD) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Drugs For Travelers' Diarrhea (TD) Revenue by Type (2021-2026) & (K Units) Table 27. Global Drugs For Travelers' Diarrhea (TD) Revenue by Type (2027-2032) & (K Units) Table 28. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Type (2021-2026) Table 29. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Adults Table 31. Major Manufacturers of Children Table 32. Global Drugs For Travelers' Diarrhea (TD) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Drugs For Travelers' Diarrhea (TD) Sales by Application (2021-2026) & (K Units) Table 34. Global Drugs For Travelers' Diarrhea (TD) Sales by Application (2027-2032) & (K Units) Table 35. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Application (2021-2026) Table 36. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Application (2027-2032) Table 37. Global Drugs For Travelers' Diarrhea (TD) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Drugs For Travelers' Diarrhea (TD) Revenue by Application (2021-2026) & (K Units) Table 39. Global Drugs For Travelers' Diarrhea (TD) Revenue by Application (2027-2032) & (K Units) Table 40. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Application (2021-2026) Table 41. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Application (2027-2032) Table 42. Global Drugs For Travelers' Diarrhea (TD) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Drugs For Travelers' Diarrhea (TD) Sales by Region (2021-2026) & (K Units) Table 44. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Region (2021-2026) Table 45. Global Drugs For Travelers' Diarrhea (TD) Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Drugs For Travelers' Diarrhea (TD) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Drugs For Travelers' Diarrhea (TD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2026) & (K Units) Table 49. North America Drugs For Travelers' Diarrhea (TD) Sales by Country (2027-2032) & (K Units) Table 50. Europe Drugs For Travelers' Diarrhea (TD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2026) & (K Units) Table 52. Europe Drugs For Travelers' Diarrhea (TD) Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales by Country (2027-2032) & (K Units) Table 59. Global Drugs For Travelers' Diarrhea (TD) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Drugs For Travelers' Diarrhea (TD) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Drugs For Travelers' Diarrhea (TD) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Region (2021-2026) Table 63. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Region (2027-2032) Table 64. Sun Pharmaceutical Industries Ltd. Company Information Table 65. Sun Pharmaceutical Industries Ltd. Business Overview Table 66. Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 68. Sun Pharmaceutical Industries Ltd. Recent Development Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Bayer AG Company Information Table 75. Bayer AG Business Overview Table 76. Bayer AG Drugs For Travelers' Diarrhea (TD) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Bayer AG Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 78. Bayer AG Recent Development Table 79. Valneva SE Company Information Table 80. Valneva SE Business Overview Table 81. Valneva SE Drugs For Travelers' Diarrhea (TD) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Valneva SE Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 83. Valneva SE Recent Development Table 84. Perrigo Company Plc Company Information Table 85. Perrigo Company Plc Business Overview Table 86. Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 88. Perrigo Company Plc Recent Development Table 89. Norgine Company Information Table 90. Norgine Business Overview Table 91. Norgine Drugs For Travelers' Diarrhea (TD) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Norgine Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 93. Norgine Recent Development Table 94. Immuron Company Information Table 95. Immuron Business Overview Table 96. Immuron Drugs For Travelers' Diarrhea (TD) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Immuron Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 98. Immuron Recent Development Table 99. COSMO PHARMACEUTICALS Company Information Table 100. COSMO PHARMACEUTICALS Business Overview Table 101. COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 103. COSMO PHARMACEUTICALS Recent Development Table 104. Bausch Health Companies Inc. Company Information Table 105. Bausch Health Companies Inc. Business Overview Table 106. Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 108. Bausch Health Companies Inc. Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Drugs For Travelers' Diarrhea (TD) Distributors List Table 112. Drugs For Travelers' Diarrhea (TD) Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Drugs For Travelers' Diarrhea (TD) Product Image Figure 2. Global Drugs For Travelers' Diarrhea (TD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs For Travelers' Diarrhea (TD) Market Size (2021-2032) & (US$ Million) Figure 4. Global Drugs For Travelers' Diarrhea (TD) Sales (2021-2032) & (K Units) Figure 5. Global Drugs For Travelers' Diarrhea (TD) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Drugs For Travelers' Diarrhea (TD) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Antidiarrheal Agents Image Figure 9. Oral Rehydration Therapy (ORS) Image Figure 10. Antibiotics Image Figure 11. Others Image Figure 12. Global Drugs For Travelers' Diarrhea (TD) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Type (2021-2032) Figure 15. Global Drugs For Travelers' Diarrhea (TD) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Type (2021-2032) Figure 18. Adults Image Figure 19. Children Image Figure 20. Global Drugs For Travelers' Diarrhea (TD) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Application (2021-2032) Figure 23. Global Drugs For Travelers' Diarrhea (TD) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Application (2021-2032) Figure 26. North America Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Drugs For Travelers' Diarrhea (TD) Sales Market Share by Country (2021-2032) Figure 28. U.S. Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Drugs For Travelers' Diarrhea (TD) Sales Market Share by Country (2021-2032) Figure 33. Germany Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales Market Share by Country (2021-2032) Figure 40. China Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales Market Share by Country (2021-2032) Figure 48. Brazil Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Drugs For Travelers' Diarrhea (TD) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Drugs For Travelers' Diarrhea (TD) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Drugs For Travelers' Diarrhea (TD) Revenue (2021-2032) & (US$ Million) Figure 59. North America Drugs For Travelers' Diarrhea (TD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Drugs For Travelers' Diarrhea (TD) Revenue (2021-2032) & (US$ Million) Figure 61. Europe Drugs For Travelers' Diarrhea (TD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Drugs For Travelers' Diarrhea (TD) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Drugs For Travelers' Diarrhea (TD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Drugs For Travelers' Diarrhea (TD) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Drugs For Travelers' Diarrhea (TD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Drugs For Travelers' Diarrhea (TD) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Drugs For Travelers' Diarrhea (TD) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Antidiarrheal Agents
  • Oral Rehydration Therapy (ORS)
  • Antibiotics
  • Others
Applications
  • Adults
  • Children
Companies covered
  • Sun Pharmaceutical Industries Ltd.
  • Johnson & Johnson
  • Bayer AG
  • Valneva SE
  • Perrigo Company Plc
  • Norgine
  • Immuron
  • COSMO PHARMACEUTICALS
  • Bausch Health Companies Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drugs For Travelers' Diarrhea (TD) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drugs For Travelers' Diarrhea (TD) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drugs For Travelers' Diarrhea (TD) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drugs For Travelers' Diarrhea (TD) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drugs For Travelers' Diarrhea (TD) Market Dynamics
  1. 2.1 Drugs For Travelers' Diarrhea (TD) Industry Trends
  2. 2.2 Drugs For Travelers' Diarrhea (TD) Industry Drivers
  3. 2.3 Drugs For Travelers' Diarrhea (TD) Industry Opportunities and Challenges
  4. 2.4 Drugs For Travelers' Diarrhea (TD) Industry Restraints
3 Drugs For Travelers' Diarrhea (TD) Market by Manufacturers
  1. 3.1 Global Drugs For Travelers' Diarrhea (TD) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drugs For Travelers' Diarrhea (TD) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drugs For Travelers' Diarrhea (TD) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drugs For Travelers' Diarrhea (TD) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drugs For Travelers' Diarrhea (TD) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drugs For Travelers' Diarrhea (TD) Manufacturers, Product Type & Application
  7. 3.7 Global Drugs For Travelers' Diarrhea (TD) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drugs For Travelers' Diarrhea (TD) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drugs For Travelers' Diarrhea (TD) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drugs For Travelers' Diarrhea (TD) Tier 1, Tier 2, and Tier 3
4 Drugs For Travelers' Diarrhea (TD) Market by Type
  1. 4.1 Drugs For Travelers' Diarrhea (TD) Type Introduction
  2. 4.1.1 Antidiarrheal Agents
  3. 4.1.2 Oral Rehydration Therapy (ORS)
  4. 4.1.3 Antibiotics
  5. 4.1.4 Others
  6. 4.2 Global Drugs For Travelers' Diarrhea (TD) Sales by Type
  7. 4.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales by Type (2021-2032)
  9. 4.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Type (2021-2032)
  10. 4.3 Global Drugs For Travelers' Diarrhea (TD) Revenue by Type
  11. 4.3.1 Global Drugs For Travelers' Diarrhea (TD) Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Drugs For Travelers' Diarrhea (TD) Revenue by Type (2021-2032)
  13. 4.3.3 Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Type (2021-2032)
5 Drugs For Travelers' Diarrhea (TD) Market by Application
  1. 5.1 Drugs For Travelers' Diarrhea (TD) Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Drugs For Travelers' Diarrhea (TD) Sales by Application
  5. 5.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales by Application (2021-2032)
  7. 5.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Application (2021-2032)
  8. 5.3 Global Drugs For Travelers' Diarrhea (TD) Revenue by Application
  9. 5.3.1 Global Drugs For Travelers' Diarrhea (TD) Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Drugs For Travelers' Diarrhea (TD) Revenue by Application (2021-2032)
  11. 5.3.3 Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Application (2021-2032)
6 Global Drugs For Travelers' Diarrhea (TD) Sales by Region
  1. 6.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drugs For Travelers' Diarrhea (TD) Sales by Region (2021-2032)
  3. 6.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Region (2021-2026)
  4. 6.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drugs For Travelers' Diarrhea (TD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drugs For Travelers' Diarrhea (TD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drugs For Travelers' Diarrhea (TD) Revenue by Region
  1. 7.1 Global Drugs For Travelers' Diarrhea (TD) Revenue by Region
  2. 7.1.1 Global Drugs For Travelers' Diarrhea (TD) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drugs For Travelers' Diarrhea (TD) Revenue by Region (2021-2026)
  4. 7.1.3 Global Drugs For Travelers' Diarrhea (TD) Revenue by Region (2027-2032)
  5. 7.1.4 Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drugs For Travelers' Diarrhea (TD) Revenue (2021-2032)
  8. 7.2.2 North America Drugs For Travelers' Diarrhea (TD) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drugs For Travelers' Diarrhea (TD) Revenue (2021-2032)
  11. 7.3.2 Europe Drugs For Travelers' Diarrhea (TD) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drugs For Travelers' Diarrhea (TD) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drugs For Travelers' Diarrhea (TD) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries Ltd.
  2. 8.1.1 Sun Pharmaceutical Industries Ltd. Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Ltd. Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Bayer AG
  14. 8.3.1 Bayer AG Company Information
  15. 8.3.2 Bayer AG Business Overview
  16. 8.3.3 Bayer AG Drugs For Travelers' Diarrhea (TD) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer AG Drugs For Travelers' Diarrhea (TD) Product Portfolio
  18. 8.3.5 Bayer AG Recent Developments
  19. 8.4 Valneva SE
  20. 8.4.1 Valneva SE Company Information
  21. 8.4.2 Valneva SE Business Overview
  22. 8.4.3 Valneva SE Drugs For Travelers' Diarrhea (TD) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Valneva SE Drugs For Travelers' Diarrhea (TD) Product Portfolio
  24. 8.4.5 Valneva SE Recent Developments
  25. 8.5 Perrigo Company Plc
  26. 8.5.1 Perrigo Company Plc Company Information
  27. 8.5.2 Perrigo Company Plc Business Overview
  28. 8.5.3 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Product Portfolio
  30. 8.5.5 Perrigo Company Plc Recent Developments
  31. 8.6 Norgine
  32. 8.6.1 Norgine Company Information
  33. 8.6.2 Norgine Business Overview
  34. 8.6.3 Norgine Drugs For Travelers' Diarrhea (TD) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Norgine Drugs For Travelers' Diarrhea (TD) Product Portfolio
  36. 8.6.5 Norgine Recent Developments
  37. 8.7 Immuron
  38. 8.7.1 Immuron Company Information
  39. 8.7.2 Immuron Business Overview
  40. 8.7.3 Immuron Drugs For Travelers' Diarrhea (TD) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Immuron Drugs For Travelers' Diarrhea (TD) Product Portfolio
  42. 8.7.5 Immuron Recent Developments
  43. 8.8 COSMO PHARMACEUTICALS
  44. 8.8.1 COSMO PHARMACEUTICALS Company Information
  45. 8.8.2 COSMO PHARMACEUTICALS Business Overview
  46. 8.8.3 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Product Portfolio
  48. 8.8.5 COSMO PHARMACEUTICALS Recent Developments
  49. 8.9 Bausch Health Companies Inc.
  50. 8.9.1 Bausch Health Companies Inc. Company Information
  51. 8.9.2 Bausch Health Companies Inc. Business Overview
  52. 8.9.3 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Product Portfolio
  54. 8.9.5 Bausch Health Companies Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drugs For Travelers' Diarrhea (TD) Value Chain Analysis
  2. 9.1.1 Drugs For Travelers' Diarrhea (TD) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drugs For Travelers' Diarrhea (TD) Production Mode & Process
  6. 9.2 Drugs For Travelers' Diarrhea (TD) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drugs For Travelers' Diarrhea (TD) Distributors
  9. 9.2.3 Drugs For Travelers' Diarrhea (TD) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst